Observations placeholder
Malarone
Identifier
019491
Type of Spiritual Experience
Background
A description of the experience
The drug combination atovaquone/proguanil (INNs, trade names Malarone, Malanil) is an antimalarial medication used in both the treatment and prevention of malaria. Atovaquone alone is not indicated for treatment or prevention of malaria as monotherapy (i.e., without proguanil).
Adverse effects
Malarone is notable for having far fewer side effects than other, older malaria drugs [sic]. While some people experience side effects, such as coughing, diarrhea, dizziness, headache, loss of appetite, mouth sores, nausea, stomach pain, vomiting, or weakness, the majority have none or few of these
On Dec, 24, 2016 2,211 people reported to have side effects when taking Malarone.
Among them, 100 people (4.52%) have Hallucination
Time on Malarone when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 92.59% | 5.56% | 0.00% | 1.85% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Malarone :
Female | Male | |
Hallucination | 43.96% | 56.04% |
Age of people who have Hallucination when taking Malarone :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 19.72% | 33.80% | 11.27% | 9.86% | 15.49% | 9.86% |
Severity of Hallucination when taking Malarone :
least | moderate | severe | most severe | |
Hallucination | 0.00% | 0.00% | 0.00% | 100.00% |
On Dec, 16, 2015: 1,982 people reported to have side effects when taking Malarone. Among them, 7 people (0.35%) have Death.
Time on Malarone when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Malarone :
Female | Male | |
Death | 57.14% | 42.86% |